Cargando…
New Product Development in the Pharmaceutical Industry: Evidence from a generic market
In today’s competitive world, there are several strategies to deal with the fast changing environment, among which New product development (NPD) is a common strategy. However, almost half of the resources that companies devote to NPD are spent on products that may fail. This issue is particularly hi...
Autores principales: | Yousefi, Nazila, Mehralian, Gholamhossein, Rasekh, Hamid Reza, Yousefi, Mina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603895/ https://www.ncbi.nlm.nih.gov/pubmed/28979339 |
Ejemplares similares
-
Identifying and prioritizing industry-level competitiveness factors: evidence from pharmaceutical market
por: Shabaninejad, Hosein, et al.
Publicado: (2014) -
Developing a Model for Agile Supply: an Empirical Study from Iranian Pharmaceutical Supply Chain
por: Rajabzadeh Ghatari, Ali, et al.
Publicado: (2013) -
Situation Analysis of R & D Activities: An Empirical Study in Iranian Pharmaceutical Companies
por: Rasekh, Hamid Reza, et al.
Publicado: (2012) -
Human Resource Management Challenges to Develop Pharmaceutical Industry: Evidence from Developing Countries
por: Babapour, Jafar, et al.
Publicado: (2018) -
How does external reference pricing work in developing countries: evidence from Iran
por: Babaie, Fatemeh, et al.
Publicado: (2023)